
Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis
Author(s) -
Winston E. Abara,
Philip R. Spradling,
Yuna Zhong,
Anne C. Moorman,
Eyasu H. Teshale,
Loralee B Rupp,
Stuart C. Gordon,
Mark Schmidt,
Joseph A. Boscarino,
Yihe G. Daida,
Scott D. Holmberg
Publication year - 2019
Publication title -
journal of gastrointestinal cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.473
H-Index - 47
eISSN - 1941-6628
pISSN - 1941-6636
DOI - 10.1007/s12029-019-00255-4
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , cohort , gastroenterology , hepatitis c virus , hepatitis c , hepatitis b virus , medical record , logistic regression , virus , immunology
Six-monthly hepatocellular carcinoma (HCC) screening in cirrhotic patients has been recommended since 2011. HCC prognosis is associated with diagnosis at an early stage. We examined the prevalence and correlates of 6-monthly HCC surveillance in a cohort of HCV-infected cirrhotic patients.